// App-Quantinova.ai

2652 : Pan-cancer analysis of programmed death-ligand 1 (PD-L1) amplifications

Researchers

Presenter

  • Jan Budczies

Principal Investigators

  • Michael Bockmayr

  • Frederick Klauschen

  • Wilko Weichert

  • Carsten Denkert

  • Albrecht Stenzinger

Medical Centers

  • Brustzentrum Charite-Universitatsmedizin, Berlin, Germany

  • Technical Univ of Munich, Munich, Germany

  • Massachusetts General Hosp Harvard Medcl School, Boston, MA

Locations

  • United States

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Programmed cell death protein 1

  • Programmed death-ligand 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved